Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.
The Scientist
Most Recent
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
A National Academies of Science panel is nearly done evaluating research institutions with a critical eye on the quality of undergraduate education.
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
To save money, an Iowa university will shut down its natural history museum and K–12 teacher-training center.
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.
Researchers with millions of grant dollars may face greater scrutiny by the funding agency.
President Obama released his proposed 2013 budget request, featuring a 1 percent increase in research spending overall.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
